NYSE · CHE
Healthcare · Medical - Care Facilities
$534.72
Down-$7.20 (-1.33%)
Updated Oct 31, 2026, 7:07 PM
SID Score
6.4/10
Composite research score
Smart Money
58/100
Neutral
Price performance · CHE
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
CHE closed at $534.72 after 21 trading sessions, up 5.36% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $545.01 | $551.68 | $533.22 | $534.72 | 180.47K |
| Oct 29, 2026 | $534.17 | $542.42 | $527.09 | $541.92 | 193.52K |
| Oct 28, 2026 | $544.93 | $562.24 | $533.13 | $533.36 | 325.18K |
| Oct 27, 2026 | $508.78 | $512.00 | $494.29 | $509.09 | 191.32K |
| Oct 26, 2026 | $515.18 | $522.34 | $510.30 | $512.90 | 127.66K |
| Oct 23, 2026 | $517.23 | $520.95 | $510.99 | $512.98 | 156.99K |
| Oct 22, 2026 | $513.60 | $522.59 | $510.1625 | $520.15 | 141.45K |
| Oct 21, 2026 | $513.06 | $516.78 | $506.255 | $511.37 | 115.69K |
| Oct 20, 2026 | $511.28 | $519.27 | $506.01 | $516.07 | 114.13K |
| Oct 19, 2026 | $507.56 | $511.8144 | $506.09 | $508.29 | 97.23K |
| Oct 16, 2026 | $518.79 | $520.885 | $509.705 | $512.38 | 89.4K |
| Oct 15, 2026 | $519.64 | $519.64 | $508.985 | $515.44 | 139.11K |
| Oct 14, 2026 | $500.89 | $513.93 | $500.89 | $513.18 | 129.94K |
| Oct 13, 2026 | $504.83 | $505.89 | $496.79 | $500.77 | 104.63K |
| Oct 12, 2026 | $501.76 | $505.87 | $499.57 | $500.64 | 119.7K |
| Oct 9, 2026 | $497.65 | $502.1475 | $493.43 | $499.82 | 134.46K |
| Oct 8, 2026 | $495.65 | $499.73 | $494.12 | $498.25 | 135.45K |
| Oct 7, 2026 | $508.32 | $514.67 | $499.52 | $501.45 | 139.13K |
| Oct 6, 2026 | $513.77 | $517.98 | $506.32 | $509.84 | 129.21K |
| Oct 5, 2026 | $505.75 | $514.455 | $500.97 | $511.30 | 139.77K |
| Oct 2, 2026 | $502.88 | $510.82 | $499.64 | $507.50 | 159.12K |
The latest Smart Investors Daily articles mentioning CHE.
Company
Market Activity
Research & News
CHE research
Company profile and research snapshot.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 29, 2026 | UBS | Buy | — |
| Oct 29, 2026 | RBC Capital | Sector Perform | — |
| Oct 29, 2026 | Oppenheimer | Outperform | — |
| Oct 28, 2026 | Jefferies | Buy | — |
| Sep 25, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 21, 2026
Looking back on senior health, home health & hospice stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) and its peers.
Yahoo · Oct 19, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 25.2% gain over the past six months, beating the S&P 500 by 16.3 percentage points.
Yahoo · Oct 15, 2026
Expansion is Expected to Extend Access to Plumbing, Drain, Sewer, and Water Cleanup Services in Additional California Markets CINCINNATI, OH - October 15, 2026 (NEWMEDIAWIRE) - Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corpora...
Yahoo · Oct 9, 2026
Over the past six months, Chemed has been a great trade, beating the S&P 500 by 11.9%. Its stock price has climbed to $493.23, representing a healthy 26.2% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CHE.
